Abstract

Colonic mucosal bft detection was significantly higher in tumor-bearing patients than in colonoscopy control patients and universal in late-stage colorectal cancer (CRC). bft-2 was the most frequent isotype identified, and multiple bft isotypes were more often present in CRC patients.